• 35492 Citations
  • 96 Scopus h-Index
19962020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Comment/debate

A new era in the management of multiple myeloma

Kumar, S. & Kyle, R. A., Jun 1 2007, In : Oncology. 21, 7, 1 p.

Research output: Contribution to journalComment/debate

Bisphosphonates in multiple myeloma: A fractured consensus

Kumar, S. K., Mar 1 2015, In : Leukemia and Lymphoma. 56, 3, p. 553-554 2 p.

Research output: Contribution to journalComment/debate

Blind men and an elephant

Kumar, S., Jan 29 2015, In : Blood. 125, 5, p. 745-747 3 p.

Research output: Contribution to journalComment/debate

Checking in: T cells against multiple myeloma

Kumar, S. K., Sep 7 2017, In : Blood. 130, 10, p. 1175-1176 2 p.

Research output: Contribution to journalComment/debate

2 Scopus citations

Combination therapy with Melphalan, Prednisone, and Thalidomide (MPT) for multiple myeloma

Kumar, S., Aug 1 2006, In : American Journal of Oncology Review. 5, 8, p. 491-494 4 p.

Research output: Contribution to journalComment/debate

Commentary on myeloma presentations

Kumar, S. & Rajkumar, S. V., Jun 15 2009, In : Clinical Advances in Hematology and Oncology. 7, 2 SUPPL. 6, p. 11-12 2 p.

Research output: Contribution to journalComment/debate

Correction: Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond (Leukemia, (2018), 32, 2, (252-262), 10.1038/leu.2017.329)

Chim, C. S., Kumar, S. K., Orlowski, R. Z., Cook, G., Richardson, P. G., Gertz, M. A., Giralt, S., Mateos, M. V., Leleu, X. & Anderson, K. C., Apr 1 2019, In : Leukemia. 33, 4, p. 1058-1059 2 p.

Research output: Contribution to journalComment/debate

Open Access

Correction: Bone marrow plasma cells 20% or greater discriminate presentation, response, and survival in AL amyloidosis (Leukemia, (2020), 34, 4, (1135-1143), 10.1038/s41375-019-0655-x)

Muchtar, E., Gertz, M. A., Kourelis, T. V., Sidana, S., Go, R. S., Lacy, M. Q., Buadi, F. K., Dingli, D., Hayman, S. R., Kapoor, P., Leung, N., Fonder, A., Hobbs, M., Hwa, Y. L., Gonsalves, W., Warsame, R., Russell, S., Lust, J. A., Lin, Y., Zeldenrust, S. & 4 others, Rajkumar, S. V., Kyle, R. A., Kumar, S. K. & Dispenzieri, A., Oct 1 2020, In : Leukemia. 34, 10, p. 2819 1 p.

Research output: Contribution to journalComment/debate

Open Access

Digging Deeper with Allogeneic Transplantation in Multiple Myeloma

Kumar, S. K., Mar 2013, In : Biology of Blood and Marrow Transplantation. 19, 3, p. 335-336 2 p.

Research output: Contribution to journalComment/debate

1 Scopus citations

Enrolment of racial minorities across 15 years of multiple myeloma randomised trials; calling on researchers to become agents of change

Mohyuddin, G. R., Koehn, K., Costa, L., Kumar, S. K. & McClune, B., Oct 2020, In : The Lancet Haematology. 7, 10, p. e704-e706

Research output: Contribution to journalComment/debate

Erratum: Racial differences in primary cytogenetic abnormalities in multiple myeloma: A multi-center study (Blood Cancer Journal (2015) 5 (e279) DOI: 10.1038/bcj.2015.8)

Greenberg, A. J., Philip, S., Paner, A., Velinova, S., Badros, A., Catchatourian, R., Ketterling, R., Kyle, R. A., Kumar, S., Vachon, C. M. & Rajkumar, S. V., Jan 1 2015, In : Blood cancer journal. 5, 2, e279.

Research output: Contribution to journalComment/debate

4 Scopus citations

Erratum: Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study (Leukemia (2012) 26 (149-157) DOI: 10.1038/leu.2011.196)

Kumar, S. K., Lee, J. H., Lahuerta, J. J., Morgan, G., Richardson, P. G., Crowley, J., Haessler, J., Feather, J., Hoering, A., Moreau, P., Leleu, X., Hulin, C., Klein, S. K., Sonneveld, P., Siegel, D., Bladeé, J., Goldschmidt, H., Jagannath, S., Miguel, J. S., Orlowski, R. & 3 others, Palumbo, A., Sezer, O. & Rajkumar, S. V., May 2012, In : Leukemia. 26, 5, p. 1153 1 p.

Research output: Contribution to journalComment/debate

4 Scopus citations

Erratum: Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients (Nature Communications (2015) 6 (7539) DOI: 10.1038/ncomms8539)

Ziv, E., Dean, E., Hu, D., Martino, A., Serie, D., Curtin, K., Campa, D., Aftab, B., Bracci, P., Buda, G., Zhao, Y., Caswell-Jin, J., Diasio, R., Dumontet, C., Dudziński, M., Fejerman, L., Greenberg, A., Huntsman, S., Jamroziak, K., Jurczyszyn, A. & 18 others, Kumar, S., Atanackovic, D., Glenn, M., Cannon-Albright, L. A., Jones, B., Lee, A., Marques, H., Martin, T., Martinez-Lopez, J., Rajkumar, V., Sainz, J., Vangsted, A. J., Watek, M., Wolf, J., Slager, S., Camp, N. J., Canzian, F. & Vachon, C., Dec 9 2015, In : Nature communications. 6, 10203.

Research output: Contribution to journalComment/debate

Lenalidomide with or without dexamethasone for relapsed or refractory multiple myeloma

Kumar, S., Nov 1 2007, In : American Journal of Hematology/ Oncology. 6, 11, p. 644-645+650

Research output: Contribution to journalComment/debate

Maintenance therapy in multiple myeloma

Kumar, S., Feb 1 2014, In : Clinical Advances in Hematology and Oncology. 12, 2, p. 133-134 2 p.

Research output: Contribution to journalComment/debate

1 Scopus citations

Monoclonal antibodies for myeloma: Make it easy!

Kumar, S. K., Jul 1 2018, In : Journal of Oncology Practice. 14, 7, p. 423-424 2 p.

Research output: Contribution to journalComment/debate

Post-transplant therapy in multiple myeloma: A hung jury?

Kumar, S., Jan 1 2014, In : The Lancet Haematology. 1, 3, p. e90-e91

Research output: Contribution to journalComment/debate

Progress in the treatment of multiple myeloma

Kumar, S., Mar 11 2006, In : Lancet. 367, 9513, p. 791-792 2 p.

Research output: Contribution to journalComment/debate

5 Scopus citations

Risk adapted therapy for multiple myeloma: Back to basics

Kumar, S. K. & Gertz, M. A., Oct 1 2014, In : Leukemia and Lymphoma. 55, 10, p. 2219-2220 2 p.

Research output: Contribution to journalComment/debate

8 Scopus citations

Surrogate endpoints in randomised controlled trials: a reality check

Kumar, S. & Rajkumar, S. V., Jul 27 2019, In : The Lancet. 394, 10195, p. 281-283 3 p.

Research output: Contribution to journalComment/debate

7 Scopus citations

Trisomies in multiple myeloma: Impact on survival in patients with high-risk cytogenetics. (Blood (2012) 119, 9 (2100-2105))

Kumar, S., Fonseca, R. & Ketterling, R. P., Mar 6 2014, In : Blood. 123, 10, p. 1621 1 p.

Research output: Contribution to journalComment/debate